ONCO (Onconetix, Inc.) Stock Market Reviews

crown

search

Read and share opinions on ONCO (Onconetix, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

ONCO

Onconetix, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Onconetix announces financing through private placement, debt settlement
Sep 27, 2025
Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.
Sep 26, 2025
Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement
Sep 26, 2025
Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM
Sep 22, 2025
Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement
Jul 16, 2025
Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel
Jun 16, 2025
Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders
Jun 11, 2025
Onconetix receives additional delisting notice from Nasdaq
May 23, 2025
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
May 22, 2025
Onconetix Signs Letter of Intent for Potential Business Combination with Ocuvex Therapeutics, Inc.
Apr 8, 2025
Onconetix claims validation of prostate cancer test Proclarix in Danish cohort
Mar 25, 2025
Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort
Mar 24, 2025
Onconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress
Mar 19, 2025
Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing
Dec 12, 2024

Reviews